A. Camm

Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA (2003)

Brouwer, I.A., Zock, P.L., Katan, M.B., Hauer, R.N.W., Camm, A., Bocker, D.I., ...

Background: Evidence from earlier studies indicates that intake of very long-chain n-3 polyunsaturated fatty acids (n-3 PUFA, also named omega-3 fatty acids) as present in fish oil reduces the risk...

Recommendations for driving of patients with implantable defibrillators (1997)

JUNG, W, ANDERSON, M, CAMM, A, Jordaens, Luc, PETCH, M, ROSENQVIST, M, ...

Clinical cardiac electrophysiology (1996)

Jordaens, Luc, CAMM, A

The electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. (1995)

BASHIR, Y, THOMSEN, P, KINGMA, J, MOLLER, M, WONG, C, COBBE, S, ...

Left atrial spontaneous contrast echoes -- markers of thromboembolic risk in patients with atrial fibrillation (1993)

DE BELDER, M. A., LOVAT, L. B., TOURIKIS, L., LEECH, G., CAMM, A.

A consecutive series of 80 patients with atrial fibrillation were studied with both precordial and transoesophageal echocardiography. Left a trial spontaneous contrast echoes were observed in one...